Treating Facial Volume Loss With Fillers For patients who want to restore lost volume and droopy skin, and rejuvenate their appearance, dermal fillers offer a safe, effective, and non-surgical solution
Common FDA-approved options include: Semaglutide Wegovy (FDA-approved for weight loss) Ozempic (FDA-approved for type 2 diabetes
Intramuscular injection can cause increased pain, faster drug absorption than intended, and a higher risk of bruising
SNAC briefly buffers the acidic environment right around the dissolving tablet, giving the semaglutide a narrow window to slip across the stomach wall intact
Retatrutide is a synthetic triple receptor agonist peptide developed by Eli Lilly that simultaneously activates three metabolic receptors: the glucose-dependent insulinotropic polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP-1R), and the glucagon receptor (GCGR)
GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists strengthened warnings on acute pancreatitis including necrotising and fatal cases
